Related Experiment Video
Updated: May 27, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
De novo giant prostatic adenocarcinoma: A rare case report
Lakshmi H Kamala1, Arun Vasudevan1, Aswin Kumar2
1Department of Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Abstract:
Giant prostatic adenocarcinoma is an extremely rare scenario with only two cases reported till date. To the best of our knowledge, our patient, a 76-year-old gentleman adds to the literature as the third case of giant prostatic adenocarcinoma and the second largest in volume. In spite of high pretreatment serum prostate-specific antigen value, he had a nonmetastatic disease that was treated successfully with radical intent, and it is the highlight of this case. He completed the planned treatment and is clinically well with no progression at 3 years.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018